Regenxbio (RGNX) Reports Q2 EPS of $0.30; Announces Positive Interim Update from RGX-314 Phase I Clinical Trial for Wet AMD
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 7.20 -0.21 (2.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.41 | 52 Week High | $25.00 | |||
| Open | $7.38 | 52 Week Low | $7.07 | |||
| Day High | $7.54 | P/E | N/A | |||
| Day Low | $7.00 | EPS | $0.00 | |||
| Volume | 1,061,615 | |||||
